GlassScriptPhysician profile
Aditya Rali
NPI 1972009827
$4,367.99
in general payments reported to CMS, 2019-2025
14 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what 79% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $598 · 2023: $1,464 · 2024: $956 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,769.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,618.79 | 2022-2024 | Constellation, Ngenuity |
| Ani Pharmaceuticals, INC. | $483.00 | 2025 | Iluvien, Purified Cortrophin Gel, Yutiq |
| Abbvie INC. | $424.85 | 2022-2025 | |
| Genentech, INC. | $399.80 | 2022-2025 | Vabysmo |
| Genentech USA, INC. | $321.23 | 2022-2025 | Susvimo, Vabysmo |
| Astellas Pharma US INC | $252.93 | 2024-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $204.14 | 2024-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $132.97 | 2025 | Eylea Hd |
| Bausch & Lomb Americas INC. | $124.43 | 2023-2025 | Stellaris, Xipere |
| Samsara Vision | $114.37 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Eyepoint US, INC. | $113.47 | 2022-2023 | |
| Dutch Ophthalmic, USA | $87.91 | 2023 | Tissueblue, Eva, Combined Machine |
| Alimera Sciences, INC. | $51.09 | 2024 | Yutiq, Iluvien |
| Sandoz INC. | $39.01 | 2024 | Cimerli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Rali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.